CXCL12 and pancreatic neoplasm: In CXCL12-treated pancreatic cancer cells, CXCR4 antagonist AMD3100 does not inhibit migration and invasion, indicating CXCR7 promotes pancreatic cancer cell migration and invasion (Figure 3) [56].